Status:
COMPLETED
CUTE (Chronic Urticaria Treatment Evaluation)
Lead Sponsor:
UCB Pharma
Conditions:
Chronic Idiopathic Urticaria
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A study to compare the clinical efficacy and safety of Levocetirizine vs. Desloratadine in patients suffering from Chronic Idiopathic Urticaria (CIU) measured by the mean pruritus severity score over ...
Eligibility Criteria
Inclusion
- \- At visit 1: Clinical history of Chronic Idiopathic Urticaria for a period of at least 6 weeks during the last 3 months without an identifiable cause
- \- At visit 2 (after a baseline period of at least 3 days): patient with adequate signs of CIU, both in terms of symptoms and severity.
Exclusion
- \- Any condition that would interfere with the evaluation of the therapeutic response.
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
886 Patients enrolled
Trial Details
Trial ID
NCT00264303
Start Date
December 1 2005
End Date
January 1 2007
Last Update
August 31 2011
Active Locations (80)
Enter a location and click search to find clinical trials sorted by distance.
1
Bruges, Belgium
2
Brussels, Belgium
3
Liège, Belgium
4
Merksem, Belgium